ITFG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.801900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.625770E-01
Normal-vs-Stage2
2.896500E-02
Normal-vs-Stage3
4.728300E-02
Normal-vs-Stage4
2.811600E-01
Stage1-vs-Stage2
4.864000E-01
Stage1-vs-Stage3
1.238160E-01
Stage1-vs-Stage4
6.949400E-01
Stage2-vs-Stage3
3.238400E-01
Stage2-vs-Stage4
3.491200E-01
Stage3-vs-Stage4
6.296300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.756000E-02
Normal-vs-AfricanAmerican
5.547700E-02
Normal-vs-Asian
1.522370E-02
Caucasian-vs-AfricanAmerican
9.096600E-01
Caucasian-vs-Asian
1.125610E-01
AfricanAmerican-vs-Asian
2.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.998400E-02
Normal-vs-Female
5.341700E-03
Male-vs-Female
3.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.435000E-01
Normal-vs-Age(41-60Yrs)
1.063790E-02
Normal-vs-Age(61-80Yrs)
4.694100E-02
Normal-vs-Age(81-100Yrs)
5.778500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.753800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.072400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.645400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.725400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.741000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.056400E-01
Normal-vs-Daily Drinker
1.626170E-02
Normal-vs-Weekly Drinker
2.525900E-02
Normal-vs-Occasional Drinker
3.220200E-02
Normal-vs-Social Drinker
1.780050E-01
Non Drinker-vs-Daily Drinker
4.730400E-01
Non Drinker-vs-Weekly Drinker
3.962400E-01
Non Drinker-vs-Occasional Drinker
9.364000E-01
Non Drinker-vs-Social Drinker
8.894400E-01
Daily Drinker-vs-Weekly Drinker
8.038600E-01
Daily Drinker-vs-Occasional Drinker
4.107400E-01
Daily Drinker-vs-Social Drinker
3.798200E-01
Weekly Drinker-vs-Occasional Drinker
3.328400E-01
Weekly Drinker-vs-Social Drinker
3.570400E-01
Occasional Drinker-vs-Social Drinker
8.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.211440E-01
Normal-vs-Grade 2
2.385200E-01
Normal-vs-Grade 3
1.594840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.041600E-01
Grade 1-vs-Grade 3
4.749800E-01
Grade 1-vs-Grade 4
1.211440E-01
Grade 2-vs-Grade 3
5.361800E-01
Grade 2-vs-Grade 4
2.385200E-01
Grade 3-vs-Grade 4
1.594840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.158640E-01
Normal-vs-NonDiabetic
1.942450E-02
Diabetic-vs-NonDiabetic
8.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.723220E-01
Normal-vs-NoPancreatitis
3.640500E-02
Pancreatitis-vs-NoPancreatitis
6.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.511650E-01
Normal-vs-N1
5.984300E-03
N0-vs-N1
2.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.081150E-01
Normal-vs-TP53-NonMutant
1.882580E-01
TP53-Mutant-vs-TP53-NonMutant
5.612600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
